The American Journal of Managed Care

IVIG Shows Promise in Protecting Older Patients With Lymphoma From COVID-19

Prophylactic intravenous immunoglobulin reduces COVID-19 infection rates in older patients with DLBCL with hypogammaglobulinemia undergoing reduced-intensity R-CHOP therapy. The study, conducted ...
The American Journal of Managed Care

Case Report: COVID-19 Risk in CLL Could Be Exacerbated by Hypogammaglobulinemia

The patient continued to test positive for COVID-19, but intravenous immunoglobulin eventually led to his recovery. People with chronic lymphocytic leukemia (CLL) are at a higher risk of contracting ...
Business Wire

Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU™ [Immune Globulin ...
MedPage Today

DLBCL: Low Immunoglobulin Levels at Diagnosis Signal Higher Risk

Low immunoglobulin levels affect nearly 1 in 4 newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL) and significantly increase infection risk during treatment. Patients with low ...
ascopubs.org

Fresh frozen plasma (FFP) for hypogammaglobulinemia (HypoG) in patients (Pts) with recurrent infections (Infxs) after B-cell directed treatment: A single institution experience ...

A cancer center department of supportive oncology: Patient demographic characteristics. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text ...
ascopubs.org

Hypogammaglobulinemia in pts receiving rituximab immunotherapy and the impact of rituximab maintenance.

Effect of YM155, a potent survivin suppressant, on the antitumor effect of rituximab in diffuse large B-cell lymphoma (DLBCL) xenograft models: FLT-/FDG-PET imaging studies. Clinical relevance of a ...